4.7 Article

Utilizing the Off-Target Effects of T1R3 Antagonist Lactisole to Enhance Nitric Oxide Production in Basal Airway Epithelial Cells

期刊

NUTRIENTS
卷 15, 期 3, 页码 -

出版社

MDPI
DOI: 10.3390/nu15030517

关键词

umami; lactisole; apoptosis; nitric oxide; airway

向作者/读者索取更多资源

Human airway taste receptors (sweet, umami, and bitter) play a crucial role in monitoring pathogenic growth. Bitter taste receptors (T2Rs) can detect bacteria or bitter compounds, leading to nitric oxide (NO) production and pathogen elimination. Sweet and umami receptors repress bitter taste receptor signaling. We propose that lactisole, a sweet/umami antagonist, can alleviate bitter taste receptor repression and enhance NO production in airway basal epithelial cells. Our study shows that lactisole activates cAMP generation and increases cytosolic Ca2+ response, ultimately leading to NO production.
Human airway sweet (T1R2 + T1R3), umami (T1R1 + T1R3), and bitter taste receptors (T2Rs) are critical components of the innate immune system, acting as sensors to monitor pathogenic growth. T2Rs detect bacterial products or bitter compounds to drive nitric oxide (NO) production in both healthy and diseased epithelial cell models. The NO enhances ciliary beating and also directly kills pathogens. Both sweet and umami receptors have been characterized to repress bitter taste receptor signaling in healthy and disease models. We hypothesized that the sweet/umami T1R3 antagonist lactisole may be used to alleviate bitter taste receptor repression in airway basal epithelial cells and enhance NO production. Here, we show that lactisole activates cAMP generation, though this occurs through a pathway independent of T1R3. This cAMP most likely signals through EPAC to increase ER Ca2+ efflux. Stimulation with denatonium benzoate, a bitter taste receptor agonist which activates largely nuclear and mitochondrial Ca2+ responses, resulted in a dramatically increased cytosolic Ca2+ response in cells treated with lactisole. This cytosolic Ca2+ signaling activated NO production in the presence of lactisole. Thus, lactisole may be useful coupled with bitter compounds as a therapeutic nasal rinse or spray to enhance beneficial antibacterial NO production in patients suffering from chronic inflammatory diseases such as chronic rhinosinusitis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据